{
  "id": "5168023b298dcd4e51000061",
  "type": "yesno",
  "question": "Is MammaPrint cleared by the United States Food and Drug Administration? ",
  "ideal_answer": "Yes. MammaPrint is cleared by the FDA for breast cancer recurrence.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/19506735",
    "http://www.ncbi.nlm.nih.gov/pubmed/21479927",
    "http://www.ncbi.nlm.nih.gov/pubmed/18786252"
  ],
  "snippets": [
    {
      "text": "Real-time RT-PCR confirmed the 5-gene prognostic signature that was distinct from an FDA-cleared 70-gene signature of MammaPrint panel and from the Oncotype DX recurrence score assay panel.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21479927",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017322",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017321",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017327",
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017326"
  ],
  "exact_answer": "Yes"
}